Search Within

Robert Maki

Formats
  1. Journal Article (141)
  2. Meeting Abstract (85)
  3. Book Section (7)
  4. Editorial (6)
  5. Review (2)
Groups
  1. Tow Center for Developmental Oncology (TCDO) (100)
  2. GSK Faculty (98)
  3. Department of Pathology and Laboratory Medicine (83)
  4. Surgery (81)
  5. Department of Medicine (68)
  6. Sarcoma Surgeons (66)

More Groups

People
  1. Cristina Antonescu (72)
  2. Samuel Singer (49)
  3. Murray Brennan (38)
  4. Gary Schwartz (32)
  5. Mary Keohan (32)
  6. David D'Adamo (27)

More People

Years
  1. 2025 (5)
  2. 2024 (17)
  3. 2023 (4)
  4. 2015 (1)
  5. 2014 (2)
  6. 2013 (7)

More Years

Publications
  1. Journal of Clinical Oncology (75)
  2. Clinical Cancer Research (22)
  3. Annals of Oncology (17)
  4. Cancer (8)
  5. Annals of Surgical Oncology (7)
  6. Cancer Research (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (77)
  2. American Association for Cancer Research (28)
  3. Oxford University Press (22)
  4. Springer (18)
  5. Elsevier Inc. (14)
  6. Lippincott Williams & Wilkins (11)

More Publishers

Results (241)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • When molecular outsmarts morphology: Malignant ossifying fibromyxoid tumors masquerading as osteosarcomas, including a novel CREBZF::PHF1 fusion
    Journal Article

    Sharma, A. E.; Dermawan, J. K.; Sherrod, A. E.; Chopra, S.; Maki, R. G.; Antonescu, C. R.
    Genes Chromosomes and Cancer (2024)

    Fulltext@MSK | Save
  • The weighted toxicity score: Confirmation of a simple metric to communicate toxicity in randomized trials of systemic cancer therapy
    Journal Article

    Jordan, J.; Maki, R. G.
    The Oncologist (2024)

    Fulltext@MSK | Save
  • Flashback foreword: Kinase mutations and imatinib response in patients with metastatic GI stromal tumor
    Editorial

    Maki, R. G.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Flashback foreword: Carboplatin dosage based on renal function
    Editorial

    Maki, R. G.; Cannistra, S. A.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Flashback Foreword: Prognostic factors in osteosarcoma
    Editorial

    Maki, R. G.; Schwartz, G. K.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Brightline-1: Phase II/III trial of the MDM2–p53 antagonist BI 907828 versus doxorubicin in patients with advanced DDLPS
    Review

    Schöffski, P.; Lahmar, M.; Lucarelli, A.; Maki, R. G.
    Future Oncology (2023)

    Fulltext@MSK | Save
  • Follow-up strategies for patients with gastrointestinal stromal tumour treated with or without adjuvant imatinib after surgery
    Journal Article

    Joensuu, H.; Martin-Broto, J.; Nishida, T.; Reichardt, P.; Schöffski, P.; Maki, R. G.
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Trivalent ganglioside vaccine and immunologic adjuvant versus adjuvant alone in metastatic sarcoma patients rendered disease-free by surgery: A randomized phase 2 trial
    Meeting Abstract

    Carvajal, R. D.; Agulnik, M.; Ryan, C. W.; Milhem, M. M.; George, S.; Jones, R. L.; Chmielowski, B.; Van Tine, B. A.; Tawbi, H. A. H.; Elias, A. D.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Primary angiosarcoma of bone a retrospective analysis of 60 patients from 2 institutions
    Journal Article

    Palmerini, E.; Maki, R. G.; Staals, E. L.; Alberghini, M.; Antonescu, C. R.; Ferrari, C.; Ruggieri, P.; Mavrogenis, A.; Bertoni, F.; Cesari, M.; more...
    American Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Treatment of advanced gastrointestinal stromal tumors in patients over 75 years old: Clinical and pharmacological implications
    Journal Article

    Italiano, A.; Saada, E.; Cioffi, A.; Poulette, S.; Bouchet, S.; Molimard, M.; Adenis, A.; Isambert, N.; Collard, O.; Le Cesne, A.; more...
    Targeted Oncology (2013)

    Fulltext@MSK | Save